New Rochelle, NY —Mounting evidence linking childhood obesity to an increasing risk of obesity, heart disease, type 2 diabetes, and other cardiovascular and metabolic disorders in adulthood is clearly presented in a comprehensive review article in the current issue of Childhood Obesity, published by Mary Ann Liebert, Inc.

The article is available free online.

Authors Megan Moriarty-Kelsey, MD and Stephen Daniels, MD, PhD, Department of Pediatrics, University of Colorado School of Medicine, caution that the rising prevalence of obesity in children will lead to higher obesity rates in the adult population, resulting in a greater health burden caused by obesity-related metabolic and cardiovascular complications. In fact, obese children may already exhibit early signs of disorders such as hypertension, elevated cholesterol levels, and insulin resistance.

In the article entitled “Childhood Obesity is the Fuel That Fires Adult Metabolic Abnormalities and Cardiovascular Disease,” the authors emphasize the importance of prevention and early intervention for childhood obesity. This not only minimizes risk of future disease, but also prevents the occurrence of disorders once thought of as conditions of adulthood that have become increasingly common in children, such as type 2 diabetes and fatty liver disease.

Childhood Obesity is a bimonthly journal, published in print and online, and is the journal of record for all aspects of communication on the broad spectrum of issues and strategies related to weight management and obesity prevention in children and adolescents. The Journal includes peer-reviewed articles documenting cutting-edge research and clinical studies, opinion pieces and roundtable discussions, profiles of successful programs and interventions, and updates on task force recommendations, global initiatives, and policy platforms. It reports on news and developments in science and medicine, features programs and initiatives developed in the public and private sector, and includes a Literature Watch and Web Watch.

Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Metabolic Syndrome and Related Disorders; Population Health Management; Diabetes Technology & Therapeutics; and Journal of Women’s Health. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, newsmagazines, and books is available at our website.